141-F:1 Statement of Purpose. – I. It is the purpose of this chapter to designate the department of health and human services as the state agency responsible for preparing information on the transmission and prevention of the human immunodeficiency virus and the hepatitis B virus. II. It is also the purpose of this chapter […]
141-F:10 Civil Liability. – Any person who purposely violates RSA 141-F:7, I or RSA 141-F:8, I and thereby discloses the identity of a person infected by a human immunodeficiency virus shall be liable to such person for actual damages, court costs and attorneys’ fees, plus a civil penalty of up to $5,000 for such […]
141-F:11 Penalty. – Any person who purposely violates the provisions of RSA 141-F:5 – 141-F:8 or any rules adopted pursuant to them shall be guilty of a misdemeanor if a natural person, or guilty of a felony if any other person. Source. 1988, 262:2, eff. April 30, 1988.
141-F:12 AIDS Drug Assistance Program Fund. – There is hereby established the AIDS drug assistance program fund. The fund shall be composed of drug rebates received on drugs purchased under the AIDS drug assistance program established pursuant to this chapter. The fund shall be nonlapsing and shall be continually appropriated to the commissioner for […]
141-F:2 Definitions. – In this chapter: I. "Antibody" means a protein produced by the body in response to specific foreign substances such as bacteria or viruses. II. "Antigen" means a substance that stimulates the production of antibodies. II-a. "Communicable hepatitis B virus infection" means the presence of both hepatitis B surface antigen and hepatitis […]
141-F:3 Powers and Duties of the Department. – The department shall: I. Provide information and guidance to the department of education for their development of courses and programs relative to the human immunodeficiency virus which meet the requirements of RSA 186:11, IX and XXVII. II. Develop training courses and materials on the human immunodeficiency […]
141-F:4 Rulemaking. – The commissioner shall adopt rules under RSA 541-A relative to: I. Procedures for testing blood samples under RSA 141-F:5, I. II. Procedures for testing body parts, tissues, or fluids under RSA 141-F:5, II. III. Procedures for confidentially testing body parts, tissues, or fluids under RSA 141-F:5, III. IV. Procedures for conducting […]
141-F:5 Consent for Testing; Exceptions. – A physician or advanced practice registered nurse licensed or registered to practice in this state, an employee of a health care facility licensed under RSA 151, whether paid or unpaid, and an employee of a blood bank, blood center, plasma center, or agency which receives blood donations, whether […]
141-F:6 Testing. – I. The department, or agencies operated by or under contract with the department, shall offer laboratory testing, in accordance with RSA 131, for the presence or absence of antibodies or antigens of the human immunodeficiency virus. II. All other laboratories, public or private, which test human blood or any other business […]
141-F:7 Reporting of Test Results. – I. Except as provided in this section, test results of samples submitted for laboratory analysis under RSA 141-F:6 shall not be disclosed to any person or agency except: (a) The physician ordering the test or the person authorized by the physician; and (b) The commissioner, in accordance with […]
141-F:8 Confidentiality; Release of Information. – I. The identity of a person tested for the human immunodeficiency virus shall not be disclosed except as provided in RSA 141-F:7 and RSA 141-F:8, III, IV and V. II. All records and any other information pertaining to a person’s testing for the human immunodeficiency virus shall be […]
141-F:9 Disease Control. – The commissioner or his designee shall conduct follow-up activities when reports of individuals found serologic positive are provided under RSA 141-C:7. I. Such activities shall be conducted with due regard to the personal and property rights of the individual person and shall be limited to discovering the potential source of […]
141-F:9-a Testing Not Required. – Nothing in this chapter shall be construed to require that health care workers be tested for the presence of the human immunodeficiency virus or the hepatitis B virus as a condition of employment or practice in a health care facility licensed in accordance with RSA 151. Source. 1993, 83:5, […]
141-F:9-b Repealed by 2007, 65:2, I, eff. Aug. 10, 2007. –
141-F:9-c Repealed by 2007, 65:2, II, eff. Aug. 10, 2007. –
141-F:9-d Repealed by 2007, 65:2, III, eff. Aug. 10, 2007. –
